Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Change in Receivables (2023 - 2025)

Lamy (LMMY) has disclosed Change in Receivables for 3 consecutive years, with $436.0 as the latest value for Q2 2025.

  • Quarterly Change in Receivables fell 88.37% to $436.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$7750.0 through Nov 2025, down 300.0% year-over-year, with the annual reading at -$11500.0 for FY2025, 200.0% down from the prior year.
  • Change in Receivables hit $436.0 in Q2 2025 for Lamy, up from -$8186.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $3875.0 in Q4 2023 to a low of -$8186.0 in Q1 2025.
  • Historically, Change in Receivables has averaged $0.0 across 3 years, with a median of $3750.0 in 2024.
  • Biggest YoY gain for Change in Receivables was 88.37% in 2025; the steepest drop was 311.25% in 2025.
  • Year by year, Change in Receivables stood at $3875.0 in 2023, then crashed by 293.55% to -$7500.0 in 2024, then surged by 105.81% to $436.0 in 2025.
  • Business Quant data shows Change in Receivables for LMMY at $436.0 in Q2 2025, -$8186.0 in Q1 2025, and -$7500.0 in Q4 2024.